Clinical Trials Logo

Fertilization clinical trials

View clinical trials related to Fertilization.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06433518 Not yet recruiting - Clinical trials for Fertilization in Vitro

BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)

BEST
Start date: July 1, 2024
Phase:
Study type: Observational [Patient Registry]

This observational clinical study aims to determine the optimal timing of ovulation triggering in women aged 35 and above with poor ovarian reserve. For this purpose, cases undergoing ovarian stimulation for assisted reproductive treatment and planned final oocyte triggering will be evaluated in two separate groups: 1. **Experimental Group**: Final oocyte triggering will be performed when the follicle or follicles measure between 13-16 mm. 2. **Control Group**: Final oocyte triggering will be performed when the follicle or follicles measure greater than 17 mm. All triggers will be administered uniformly with 6500 units of recombinant hCG and 0,2 mg triptorelin injections. The primary outcome of the study will be the number of mature oocytes. Secondary outcomes will include fertilization rates, embryo counts, and implantation rates. Primary and secondary outcomes will be compared between the two groups.

NCT ID: NCT04523103 Not yet recruiting - Fertilization Clinical Trials

Artificial Assisted Activation Following in Fertilization Failure

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Fertilization failure is a common problem in assisted reproductive Technology (ART). The main reason for fertilization failure of conventional IVF fertilization is sperm penetration failure, and the main reason of ICSI is insufficient oocyte activation. Artificial assisted activation may provide an effective technique to rescue fertilization failure. In this study, standard ICSI procedures were applied to save fertilization failure of unfertilized mature oocytes in IVF cycles. The unfertilized mature oocytes after ICSI were activated by calcium ion, or injected with calcium chloride/activated with mechanical stimulated and then transfer to calcium ion to improve fertilization. In this study, different artificial assisted activation methods were used to save the fertilization failure and assess its effective and subsequent embryo development potential.

NCT ID: NCT04519918 Not yet recruiting - Fertilization Clinical Trials

Clinical Application of Artificial Oocyte Activation Technique (AOA) in ART

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Oocyte activation is an imperative stage in the initiation of embryo development during the fertilization. Indeed, the entrance of sperm into the oocyte causes sequences of calcium oscillations in its cytoplasm, regulating a series of molecular events called oocyte activation. The intracytoplasmic sperm injection (ICSI) has allowed fertilization in couples with severe male factor infertility. But, there was still fertilization failure or low fertilization occurs in ICSI cycles. It has reported that insufficient of oocyte activation is the important cause of fertilization failure. Artificial oocyte activation (AOA) represents an effective technique, can restore the calcium oscillations to improve the fertilization. Here, the investigators explore the effective of different AOA methods including oocyte was injected CaCl2 or mechanical stimulated then treated with calcium ionophore.